The Checkerboard Tissue Microarray (TMA) method, developed by scientists at the Institute of Cancer Research, looks for the multiple markers of various genes associated with prostate cancer - including the E2F3 gene. "Overexpression" of E2F3 - first identified by the institute - is a marker of how aggressive cancer will be. (scotsman.com)

July 15, 2005

In a Mediterranean population typically at low risk for developing melanoma, carriers of mutations in the pigmentation gene MC1R are at increased risk of developing the skin cancer and having it progress, a study hints. (UPMC Cancer Centers)

Posted by news editor | Filed under: Melanoma